I think it's great Merck came up with a drug showing real promise, but do worry this will further encourage folks to not get vaccined.You're not the only one who worries about this. I really can't predict how that new drug will be accepted by the unvaccinated.\n\nIt should be easy to take – one course is 10 pills – twice daily for 5 days. The only problem I see is that it's effective if a person takes it within the first 5 days after testing positive for Covid-19. It apparently was tested in hospitalized people, with more advanced Covid-19, and it wasn't effective. So unvaccinated people must be tested more often if they expect to benefit from molnupiravir.\nWhat I can't understand is why the these folks mistrust the drug companies and medical community when it comes to vaccines, but trust the same companies and communities when it comes to what I imagine will be a much more expensive treatment with likely side effects.From what little I know about molnupiravir, it seems like it should be easy to manufacture, and might be cheap. I don't know anything about it's side effects, but safety data from the molnupiravir clinical trials will be on the table when the FDA looks at it. Merck did announce plans to seek an Emergency Use Authorization (EUA) from the FDA, so that will be soon.\n\nMerck also plans to submit marketing applications to other drug regulators around the world. The company also announced plans to license the drug to generic manufacturers, to accelerate its availability. In addition to the USA, various other countries have reported interest in negotiating with Merck to procure stocks of molnupiravir pills, including the UK, South Korea, and Malaysia. So, I don't think anyone could reasonably accuse Merck of trying to profiteer from molnupiravir.\n\nWe'll have to wait & see what the unreasonable have to say.